QGEN - QIAGEN N.V.
42.47
0.400 0.942%
Share volume: 976,764
Last Updated: 04-28-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.12%
PREVIOUS CLOSE
CHG
CHG%
$42.07
0.40
0.01%
Fundamental analysis
24%
Profitability
28%
Dept financing
16%
Liquidity
37%
Performance
19%
Performance
5 Days
-1.37%
1 Month
5.78%
3 Months
-2.97%
6 Months
1.53%
1 Year
0.40%
2 Year
-5.12%
Key data
Stock price
$42.47
DAY RANGE
$42.04 - $42.60
52 WEEK RANGE
$37.63 - $47.93
52 WEEK CHANGE
$0.33
DIVIDEND
$1.26
EX-DIVIDEND DATE
01-29-2025
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Thierry Bernard
Region: US
Website: qiagen.com
Employees: 6,030
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Region: US
Website: qiagen.com
Employees: 6,030
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring.
Recent news
